Philip Berry

507 total citations
17 papers, 224 citations indexed

About

Philip Berry is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Philip Berry has authored 17 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Biochemistry. Recurrent topics in Philip Berry's work include Antioxidant Activity and Oxidative Stress (5 papers), Neuroblastoma Research and Treatments (4 papers) and Retinoids in leukemia and cellular processes (4 papers). Philip Berry is often cited by papers focused on Antioxidant Activity and Oxidative Stress (5 papers), Neuroblastoma Research and Treatments (4 papers) and Retinoids in leukemia and cellular processes (4 papers). Philip Berry collaborates with scholars based in United Kingdom, United States and Italy. Philip Berry's co-authors include Georg Lietz, Anthony Oxley, Alan V. Boddy, Jennifer Lynn Ford, Michael H. Green, Joanne Balmer Green, Gareth J. Veal, John E. Hesketh, Dunja Przulj and Julie Errington and has published in prestigious journals such as Cancer Research, The FASEB Journal and Journal of Nutrition.

In The Last Decade

Philip Berry

17 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Berry United Kingdom 9 119 69 48 42 31 17 224
James M. Lewis United States 10 153 1.3× 17 0.2× 73 1.5× 15 0.4× 11 0.4× 31 384
Wael Sakr United States 6 86 0.7× 82 1.2× 74 1.5× 21 0.5× 21 0.7× 8 350
Michael D. Scheiber United States 9 49 0.4× 13 0.2× 55 1.1× 53 1.3× 68 2.2× 18 397
Kasumi Satoh Japan 6 45 0.4× 17 0.2× 32 0.7× 48 1.1× 10 0.3× 39 265
Changrui Wu China 10 213 1.8× 39 0.6× 14 0.3× 23 0.5× 37 1.2× 24 434
Ki Heon Lee South Korea 15 98 0.8× 14 0.2× 67 1.4× 10 0.2× 99 3.2× 34 508
Lintje Ho Netherlands 7 68 0.6× 64 0.9× 7 0.1× 19 0.5× 20 0.6× 9 298
Marcelo Dantas Tavares de Melo Brazil 9 78 0.7× 7 0.1× 55 1.1× 6 0.1× 14 0.5× 41 315
Jan L. Eccles Australia 7 40 0.3× 49 0.7× 17 0.4× 16 0.4× 69 2.2× 13 294
Emily Hacker United States 8 55 0.5× 5 0.1× 12 0.3× 11 0.3× 12 0.4× 24 252

Countries citing papers authored by Philip Berry

Since Specialization
Citations

This map shows the geographic impact of Philip Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Berry more than expected).

Fields of papers citing papers by Philip Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Berry. The network helps show where Philip Berry may publish in the future.

Co-authorship network of co-authors of Philip Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Berry. A scholar is included among the top collaborators of Philip Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Berry. Philip Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Berry, Philip, Julie Errington, Philip D. Jeffrey, et al.. (2021). Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study. Bioanalysis. 13(2). 101–113. 26 indexed citations
2.
Berry, Philip, Julie Errington, Jizhong Liu, et al.. (2019). Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial. European Journal of Cancer. 120. 75–85. 21 indexed citations
3.
Chen, Lindi, Fabio Pastorino, Philip Berry, et al.. (2018). Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma. International Journal of Cancer. 144(12). 3146–3159. 26 indexed citations
4.
Berry, Philip, et al.. (2018). Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. BMC Research Notes. 11(1). 520–520. 4 indexed citations
5.
Coulthard, Sally A., et al.. (2018). Three Faces of Mercaptopurine Cytotoxicity In Vitro: Methylation, Nucleotide Homeostasis, and Deoxythioguanosine in DNA. Drug Metabolism and Disposition. 46(8). 1191–1199. 11 indexed citations
6.
Veal, Gareth J., et al.. (2017). Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey. BMJ Paediatrics Open. 1(1). e000170–e000170. 1 indexed citations
7.
8.
Chen, Lindi, Fabio Pastorino, Philip Berry, et al.. (2017). Abstract LB-300: In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in TP53 wild-type orthotopic models of neuroblastoma. Cancer Research. 77(13_Supplement). LB–300. 1 indexed citations
9.
Berry, Philip, Julieann Sludden, Florence I. Raynaud, et al.. (2017). Development and Validation of A LC–MS/MS Method for The Quantification of The Checkpoint Kinase 1 Inhibitor Sra737 in Human Plasma. Bioanalysis. 9(13). 1001–1010. 4 indexed citations
10.
11.
Green, Michael H., Jennifer Lynn Ford, Anthony Oxley, et al.. (2016). Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores. Journal of Nutrition. 146(10). 2129–2136. 28 indexed citations
12.
Green, Michael H., Jennifer Lynn Ford, Joanne Balmer Green, et al.. (2016). A Retinol Isotope Dilution Equation Predicts Both Group and Individual Total Body Vitamin A Stores in Adults Based on Data from an Early Postdosing Blood Sample. Journal of Nutrition. 146(10). 2137–2142. 31 indexed citations
13.
Lietz, Georg, Anthony Oxley, Philip Berry, et al.. (2015). β‐carotene (BC) bioconversion is similar in men and women. The FASEB Journal. 29(S1). 1 indexed citations
14.
Mould, Emily, Philip Berry, David Jamieson, et al.. (2014). Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity. Biochemical Pharmacology. 88(1). 58–65. 13 indexed citations
15.
Oxley, Anthony, Philip Berry, Michael J. Hall, et al.. (2013). An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion, and vitamin A status in humans. Journal of Lipid Research. 55(2). 319–328. 34 indexed citations
16.
Oxley, Anthony, Philip Berry, John E. Hesketh, Alan V. Boddy, & Georg Lietz. (2013). Gender differences in retinol metabolism are independent of β-carotene bioconversion. Proceedings of The Nutrition Society. 72(OCE4). 2 indexed citations
17.
Oxley, Anthony, Philip Berry, Michael J. Hall, et al.. (2013). An LC-MS/MS method for stable isotope dilution studies of γ-carotene bioefficacy and vitamin A status in humans. Proceedings of The Nutrition Society. 72(OCE4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Lewis Breakdown of academic impact, for papers by Wael Sakr Breakdown of academic impact, for papers by Michael D. Scheiber Breakdown of academic impact, for papers by Kasumi Satoh Breakdown of academic impact, for papers by Changrui Wu Breakdown of academic impact, for papers by Ki Heon Lee Breakdown of academic impact, for papers by Lintje Ho Breakdown of academic impact, for papers by Marcelo Dantas Tavares de Melo Breakdown of academic impact, for papers by Jan L. Eccles Breakdown of academic impact, for papers by Emily Hacker
Rankless by CCL
2026